CSG Pursues Indian Joint Venture and Drone Defence Tie-Up as BofA Stays Bearish

CSG forms an India joint venture with Adani and joins the US SwarmShot counter-drone programme, as BofA warns ammunition margins may not hold.

CSG is pushing ahead on two fronts simultaneously — a new joint venture in India with the Adani group and a drone-interceptor programme in the United States — even as analysts question whether the defence contractor's ammunition margins can hold up.

Adani Partnership Opens South Asian Door

The Czech-based arms manufacturer has teamed up with the business empire of Indian billionaire Gautam Adani to establish a joint venture aimed at building a defence business on the subcontinent, according to a report by Czech business daily e15. The move is designed to give CSG a foothold in the Indian market and establish local manufacturing capacity.

India has been pouring money into modernising its armed forces and increasingly favours partnerships with foreign firms willing to produce on Indian soil. Neither side has disclosed financial terms or specific contract conditions. The Indian venture forms part of a broader internationalisation drive that also includes overseas engagements.

Federal Ammunition Joins SwarmShot Programme

On the US side, CSG's subsidiary Federal Ammunition entered the development of the autonomous counter-drone system SwarmShot on Thursday, working alongside American partners O.F. Mossberg & Sons and Palladyne AI. The reusable, airborne interceptor is designed to combine specialised shotgun ammunition and a lightweight weapon module with autonomous flight control. CSG is targeting the rapidly growing global demand for cost-effective solutions against unmanned aerial vehicles.

The collaboration coincides with CSG's first appearance at the AUSA industry exhibition in Washington, which opens on 12 October. From 12 to 14 October, the group will display exhibits from its CSG Defence Systems and CSG Ammo+ divisions, including Tatra Force military vehicles. While the trade-show announcement was not tied to any new firm orders, it underscores the European company's intent to expand its footprint in the North American defence market. No timeline or financial details of the SwarmShot agreement have been released.

BofA Flags Margin Vulnerability

The expansion into new technology areas comes against a shifting market backdrop. Bank of America analyst David Holmes initiated coverage of the stock on 1 October with an "Underperform" rating and a price target of 13 euros. Holmes argued that CSG's ammunition margins, which recently exceeded 30%, are unlikely to be sustained as European production capacity ramps up and demand shifts from acute wartime needs toward stockpiling. He also pointed to the group's greater susceptibility to cyclical swings in inventory replenishment compared with other defence companies.

The cautious stance has weighed on the shares. CSG closed Friday's session at 14.06 euros, down 0.8% on the day, giving the company a market capitalisation of 14.07 billion euros. The stock sits 61% below its 52-week high of 36.05 euros. Roughly two weeks ago, the group did secure a Latvian artillery project worth a three-digit million-euro sum, with TATRA DEFENCE SYSTEMS acting as prime contractor for MORANA artillery and rocket launchers — yet the share price has remained under pressure.

Quiet Period Begins Ahead of Q3 Update

A quieter stretch now begins for CSG. According to the company, a multi-week quiet period ahead of its next earnings release starts on Monday. Investors will get fresh insight into operational developments on 11 November, when the trading update for the third quarter of 2026 is scheduled. In the meantime, the group will present its defence and ammunition offerings — along with Tatra-branded vehicles — at the three-day AUSA exhibition in Washington. Whether the US technology initiatives can reignite the growth narrative will depend on future contract wins.